Secondary repopulating ability of CD34+ and IBMI-CD34− SRCs
Type and no. of cells transplanted into PR* . | % Human cells in PR† . | Sorted cells transplanted into SR . | Incidence of engraftment in SR . | % Human cells in SR‡ . |
---|---|---|---|---|
Lin−CD34high, 5 × 104 | 31.4-80.0 (72.1)2-153 | CD45+CD34+ | 11/15 | 0.1-11 (4.7)2-153 |
CD45+CD34− | 0/15 | 0 | ||
Lin−CD34−, 5 × 104 | 15.3-39.6 (23.4)2-153 | CD45+CD34+ | 4/5 | 0.1-0.9 (0.15)2-153 |
CD45+CD34− | 0/5 | 0 |
Type and no. of cells transplanted into PR* . | % Human cells in PR† . | Sorted cells transplanted into SR . | Incidence of engraftment in SR . | % Human cells in SR‡ . |
---|---|---|---|---|
Lin−CD34high, 5 × 104 | 31.4-80.0 (72.1)2-153 | CD45+CD34+ | 11/15 | 0.1-11 (4.7)2-153 |
CD45+CD34− | 0/15 | 0 | ||
Lin−CD34−, 5 × 104 | 15.3-39.6 (23.4)2-153 | CD45+CD34+ | 4/5 | 0.1-0.9 (0.15)2-153 |
CD45+CD34− | 0/5 | 0 |
5 × 104 Lin−CD34highcells were estimated to contain 40 to 50 SRCs. In contrast, 5 × 104 Lin−CD34− cells contained only 2 or 3 SRCs.
Human cell repopulation of BMs in primary recipients (PR) was serially analyzed 8 to 16 weeks after transplantation with Lin−CD34high cells and 12 to 16 weeks after transplantation with Lin−CD34− cells.
Human cell repopulation of BMs in secondary recipients (SR) was analyzed 12 weeks after secondary transplantation.
Median values are presented in parentheses.